Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 Q2- Text added to 2020 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
aberrant, acid, alongside, amide, antibody, biomarker, Biotech, bispecific, CAR, COG, cornerstone, cycle, detail, detailed, distinct, explore, exploring, FAAH, fatty, Fred, hematologic, hematology, Hutch, Hutchinson, hydrolase, Ireland, Janssen, Jazz, kinase, lock, malignant, metastatic, mitogen, modulate, mutated, opportunity, pace, placement, protein, ranking, resuming, resumption, surgically, teclistamab, underwritten
Removed:
adaptive, ADC, adjusted, belantamab, comprehensive, conjugate, freely, half, restriction, standalone, tradable
Valuein 2020 Q2 filing- Value in 2020 Q3 filing
Original filings
Filing view